PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35409412-8	2022	These data implied that Etravirine and Dolutegravir may serve as general spike inhibitors against dominant viral variants of SARS-CoV-2.	dolutegravir	39-51	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	73-78